Protara Therapeutics Newsroom

TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating

Futu NewsDec 6 20:32

H.C. Wainwright Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $23

Futu NewsDec 6 19:31

Protara Therapeutics Analyst Ratings

BenzingaDec 6 19:15

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

BenzingaDec 6 19:15

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

BenzingaNov 14 19:56

Oppenheimer Maintains Protara Therapeutics(TARA.US) With Buy Rating, Cuts Target Price to $25

Futu NewsNov 13 21:31

Oppenheimer Sticks to Their Buy Rating for Protara Therapeutics (TARA)

TipRanksNov 13 21:10

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), MoonLake Immunotherapeutics (MLTX) and Protara Therapeutics (TARA)

TipRanksSep 12 19:37

TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating

Futu NewsSep 10 08:31

Protara Therapeutics Analyst Ratings

BenzingaAug 12 21:44

Protara Therapeutics Analyst Ratings

BenzingaAug 8 19:35

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

BenzingaAug 8 19:35

Protara Therapeutics Analyst Ratings

BenzingaMay 6 18:45

Protara Therapeutics (TARA) Receives a Buy From Oppenheimer

TipRanksApr 22 19:30

Protara Therapeutics Analyst Ratings

BenzingaApr 22 19:25

HC Wainwright & Co. : Maintaining the Protara Therapeutics (TARA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $23.00 to $23.00.

Zhitong FinanceApr 8 19:20

Protara Therapeutics Analyst Ratings

BenzingaApr 8 19:20

Protara Therapeutics Analyst Ratings

BenzingaMar 14 19:15

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

BenzingaMar 14 19:15

Analysts Conflicted on These Healthcare Names: Cadrenal Therapeutics, Inc. (CVKD), Protara Therapeutics (TARA) and Spruce Biosciences (SPRB)

TipRanksMar 14 18:35